BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36961978)

  • 1. High Accuracy Prediction of PROTAC Complex Structures.
    Ignatov M; Jindal A; Kotelnikov S; Beglov D; Posternak G; Tang X; Maisonneuve P; Poda G; Batey RA; Sicheri F; Whitty A; Tonge PJ; Vajda S; Kozakov D
    J Am Chem Soc; 2023 Apr; 145(13):7123-7135. PubMed ID: 36961978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
    Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
    J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic Detection of E3:PROTAC:Target Ternary Complexes Using NanoBRET Technology in Live Cells.
    Mahan SD; Riching KM; Urh M; Daniels DL
    Methods Mol Biol; 2021; 2365():151-171. PubMed ID: 34432243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Prediction of PROTAC-Compatible Protein-Protein Interfaces by Molecular Docking.
    Pereira GP; Jiménez-García B; Pellarin R; Launay G; Wu S; Martin J; Souza PCT
    J Chem Inf Model; 2023 Nov; 63(21):6823-6833. PubMed ID: 37877240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes.
    Zaidman D; Prilusky J; London N
    J Chem Inf Model; 2020 Oct; 60(10):4894-4903. PubMed ID: 32976709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic and Structural Features of PROTAC Ternary Complexes.
    Casement R; Bond A; Craigon C; Ciulli A
    Methods Mol Biol; 2021; 2365():79-113. PubMed ID: 34432240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta.
    Bai N; Miller SA; Andrianov GV; Yates M; Kirubakaran P; Karanicolas J
    J Chem Inf Model; 2021 Mar; 61(3):1368-1382. PubMed ID: 33625214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
    Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
    Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of E3 Ligase Ligands for Target Protein Degradation.
    Lee J; Lee Y; Jung YM; Park JH; Yoo HS; Park J
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for computer-assisted PROTAC design.
    Rovers E; Schapira M
    Methods Enzymol; 2023; 690():311-340. PubMed ID: 37858533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROTAC-DB 2.0: an updated database of PROTACs.
    Weng G; Cai X; Cao D; Du H; Shen C; Deng Y; He Q; Yang B; Li D; Hou T
    Nucleic Acids Res; 2023 Jan; 51(D1):D1367-D1372. PubMed ID: 36300631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate.
    Roy MJ; Winkler S; Hughes SJ; Whitworth C; Galant M; Farnaby W; Rumpel K; Ciulli A
    ACS Chem Biol; 2019 Mar; 14(3):361-368. PubMed ID: 30721025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native mass spectrometry and gas-phase fragmentation provide rapid and in-depth topological characterization of a PROTAC ternary complex.
    Song JH; Wagner ND; Yan J; Li J; Huang RY; Balog AJ; Newitt JA; Chen G; Gross ML
    Cell Chem Biol; 2021 Oct; 28(10):1528-1538.e4. PubMed ID: 34081921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs.
    Bondeson DP; Smith BE; Buhimschi AD
    Methods Mol Biol; 2021; 2365():135-150. PubMed ID: 34432242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization.
    Schwalm MP; Krämer A; Dölle A; Weckesser J; Yu X; Jin J; Saxena K; Knapp S
    Cell Chem Biol; 2023 Jul; 30(7):753-765.e8. PubMed ID: 37354907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
    Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
    Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach.
    Chen Q; Liu C; Wang W; Meng X; Cheng X; Li X; Cai L; Luo L; He X; Qu H; Luo J; Wei H; Gao S; Liu G; Wan J; Israel DI; Li J; Dou D
    ACS Chem Biol; 2023 Jan; 18(1):25-33. PubMed ID: 36606710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.
    Khan S; He Y; Zhang X; Yuan Y; Pu S; Kong Q; Zheng G; Zhou D
    Oncogene; 2020 Jun; 39(26):4909-4924. PubMed ID: 32475992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins.
    Yokoo H; Tsuji G; Inoue T; Naito M; Demizu Y; Ohoka N
    Bioorg Chem; 2024 Apr; 145():107204. PubMed ID: 38377822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating the role of cooperativity in the design of potent PROTACs for BTK.
    Zorba A; Nguyen C; Xu Y; Starr J; Borzilleri K; Smith J; Zhu H; Farley KA; Ding W; Schiemer J; Feng X; Chang JS; Uccello DP; Young JA; Garcia-Irrizary CN; Czabaniuk L; Schuff B; Oliver R; Montgomery J; Hayward MM; Coe J; Chen J; Niosi M; Luthra S; Shah JC; El-Kattan A; Qiu X; West GM; Noe MC; Shanmugasundaram V; Gilbert AM; Brown MF; Calabrese MF
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7285-E7292. PubMed ID: 30012605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.